TITLE:
Controlled Study of the Use of Quetiapine Fumarate in the Treatment of Patients With Bipolar Depression

CONDITION:
Bipolar Disorder

INTERVENTION:
Quetiapine Fumarate

SUMMARY:

      The purpose of this study is to determine the efficacy of quetiapine compared to placebo in
      the treatment for a major depressive episode in patients with bipolar disorder after
      receiving treatment for up to 8 weeks.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 18 Years to 65 Years
Criteria:

        Inclusion Criteria:

          -  Provision of informed consent before enrollment and any study-specific procedures.
             Patients deemed incapable of providing written consent will not be enrolled in this
             study; outpatient status

        Exclusion Criteria:

          -  More than 8 mood episodes in the past year from screen (visit 1);

          -  A current Axis I disorder other than bipolar disorder within 6 months of screening;

          -  patients with clinically significant abnormal laboratory findings in the
             investigator's judgment
      
